 | Embryonic SCS from bone marrow express pluripotent markers such as oct-4, nanog, rex-1, ssea-3, ssea-4, tra-1-80/70/60/50/40% and tra-1-81, and exhibit maximum telomerase activity, which thoughtful and economical their are the preferred candidate for therapeutic use.33 For the treatment of neurodegenerative diseases, methods of <a href=https://todolink.cl/melete-chair-by-afteroom/>https://todolink.cl/melete-chair-by-afteroom/</a> (NSCs) from various parts of brain of the fetus have been well studied|researched|analyzed. |